1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High quality neoantigens are immunoedited in long-term pancreatic cancer survivors
    Meeting Abstract

    Rojas, L. A.; Łuksza, M.; Sethna, Z. M.; Soares, K.; Leung, J.; Lihm, J.; Hoyos, D.; Dobrin, A.; Kappagantula, R.; Makohon-Moore, A.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Efficacy of checkpoint inhibitors (CPIs) in acral melanoma (AM)
    Meeting Abstract

    Bhave, P.; Ahmed, T.; Shoushtari, A.; Zaremba, A.; Versluis, J.; Mangana, J.; Weichenthal, M.; Si, L.; Lesimple, T.; Robert, C.; more...
    Asia-Pacific Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Outcomes and utilization trends of front-line autologous hematopoietic cell transplantation for mantle cell lymphoma
    Journal Article

    Riedell, P. A.; Hamadani, M.; Ahn, K. W.; Litovich, C.; Murthy, G. S. G.; Locke, F. L.; Brunstein, C. G.; Merryman, R. W.; Stiff, P. J.; Pawarode, A.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Oral proteasome inhibitor ixazomib for switch-maintenance prophylaxis of recurrent or late acute and chronic graft-versus-host disease after day 100 in allogeneic stem cell transplantation
    Journal Article

    Rodriguez, N.; Lee, J.; Flynn, L.; Murray, F.; Devlin, S. M.; Soto, C.; Cho, C.; Dahi, P.; Giralt, S.; Perales, M. A.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • A prospective cohort study comparing long-term outcomes with and without palifermin in patients receiving hematopoietic cell transplantation for hematologic malignancies
    Journal Article

    Saber, W.; Steinert, P.; Zhang, M. J.; Chen, M.; Pope, A.; Keating, A.; Wingard, J. R.; Ballen, K.; Stiff, P.; Perales, M. A.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2020 highly morbid forms report
    Journal Article

    Wolff, D.; Radojcic, V.; Lafyatis, R.; Cinar, R.; Rosenstein, R. K.; Cowen, E. W.; Cheng, G. S.; Sheshadri, A.; Bergeron, A.; Williams, K. M.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Outcomes of allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A systematic review and meta-analysis
    Review

    Bewersdorf, J. P.; Sheth, A. H.; Vetsa, S.; Grimshaw, A.; Giri, S.; Podoltsev, N. A.; Gowda, L.; Tamari, R.; Tallman, M. S.; Rampal, R. K.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis
    Review

    Stoll, J. R.; Willner, J.; Oh, Y.; Pulitzer, M.; Moskowitz, A.; Horwitz, S.; Myskowski, P.; Noor, S. J.
    Journal of the American Academy of Dermatology (2021)

    Fulltext@MSK | Save
  • Phase II trial of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Shah, G.; Schöder, H.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Ryu, S.; Sohail, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Association of plasma circulating tumor DNA with diagnosis of metastatic uveal melanoma
    Research Letter

    Francis, J. H.; Canestraro, J.; Brannon, A. R.; Barker, C. A.; Berger, M.; Shoushtari, A. N.; Abramson, D. H.
    JAMA Ophthalmology (2021)

    Fulltext@MSK | Save